Rogier Rooswinkel

Prepare for Meeting →

General Partner

Forbion

Check size: Forbion does not publish one standard current check-size range across its funds on the official site.

Investment Thesis

Rogier Rooswinkel invests or supports investments through Forbion's published strategy: Invest globally in companies transforming human health and the bioeconomy, from company creation and early stage through growth.

What Excites Them

World-class science, experienced teams and differentiated products capable of producing major health or planetary outcomes.

What They Pass On

Opportunities without a strong biotechnology, health or bioeconomy basis and credible scientific evidence are less aligned.

How to Pitch

Present the science, validation, IP, team, development and regulatory plan, market and value-inflection milestones.

Notable Writing

No writing has been linked yet. Kit can search for posts, interviews, and fund essays worth reading before outreach.

Podcast Appearances

No podcast appearances are linked yet. Ask Kit to check for interviews that reveal how this investor thinks.

Key Quotes

Quote coverage is incomplete. Kit can look for direct comments on markets, founders, and investment criteria.

Background

Rogier Rooswinkel is a current General Partner at Forbion, according to the firm's official roster. No additional background is inferred where the firm does not publish a biography.

Share
Requests are processed by our agent pipeline nightlyIs this you? Request removal